Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Annals of Internal Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 10896637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

  1999cited by this paper
• Novel inflammatory markers of coronary risk: theory versus practice.

  1999cited by this paper
• Cardiovascular disease and risk factors in adults with hypopituitarism

  1999cited by this paper
• Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy.

  1999cited by this paper
• Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency.

  1999cited by this paper
• Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women.

  1999cited by this paper
• Endothelial dysfunction in hypopituitary adults with growth hormone deficiency

  1999cited by this paper
• Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.

  1999cited by this paper
• Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.

  1999cited by this paper
• Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency.

  1998cited by this paper
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values.

  1998cited by this paper
• A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.

  1998cited by this paper
• C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.

  1998cited by this paper
• The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

  1998cited by this paper
• Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

  1998cited by this paper
• Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

  1998cited by this paper
• Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience.

  1997cited by this paper
• Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.

  1997cited by this paper
• Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

  1997cited by this paper
• Growth hormone attenuates the acute-phase response to thermal injury.

  1997cited by this paper
• The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial.

  1997cited by this paper
• The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone-deficient adults.

  1997cited by this paper
• Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes.

  1997cited by this paper
• Increased arterial intima-media thickness in childhood-onset growth hormone deficiency.

  1997cited by this paper
• Increased cerebrovascular mortality in patients with hypopituitarism

  1997cited by this paper
• Low‐dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency

  1996cited by this paper
• Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production.

  1996cited by this paper
• Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall.

  1996cited by this paper
• Molecular mechanism of growth hormone action.

  1996cited by this paper
• Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial.

  1996cited by this paper
• Elevated levels of interleukin-6 in unstable angina.

  1996cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Effects of Physiologic Growth Hormone Therapy on Bone Density and Body Composition in Patients with Adult-Onset Growth Hormone Deficiency

  1996cited by this paper
• The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.

  1995cited by this paper
• Growth hormone and insulinlike growth factor I enhance host defense in a murine sepsis model.

  1995cited by this paper
• Effect of short-term treatment with recombinant human growth hormone on lipids and lipoproteins in women and men without growth hormone disturbances.

  1995cited by this paper
• Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo(a) and ApoE phenotypes.

  1995cited by this paper
• The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.

  1995cited by this paper
• Growth hormone-deficient adults are insulin-resistant.

  1995cited by this paper
• Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)

  1994cited by this paper
• The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

  1994cited by this paper
• Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.

  1994cited by this paper
• Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose‐dependent manner and suppresses circadian thyrotrophin levels: studies in GH‐deficient adults

  1994cited by this paper
• Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.

  1993cited by this paper
• Cardiovascular risk factors in adult patients with growth hormone deficiency.

  1993cited by this paper
• A prospective study of lipoprotein(a) and the risk of myocardial infarction.

  1993cited by this paper
• Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations.

  1993cited by this paper
• Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.

  1993cited by this paper
• Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency.

  1993cited by this paper
• Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis.

  1992cited by this paper
• The growth hormone deficiency syndrome in adults

  1992cited by this paper
• Body composition in growth hormone-deficient adults.

  1992cited by this paper
• Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults.

  1992cited by this paper
• Growth hormone treatment of adults withgrowth hormone deficiency: results of a 13‐month placebo controlled cross‐over study

  1992cited by this paper
• [Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution?].

  1991cited by this paper
• Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants.

  1991cited by this paper
• Premature mortality due to cardiovascular disease in hypopituitarism.

  1990cited by this paper
• Beneficial effects of growth hormone treatment in GH-deficient adults.

  1989cited by this paper
• The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.

  1989cited by this paper

• Circulating Immune and Endocrine Markers in Currently Drinking and Abstinent Individuals With Alcohol Use Disorder and Controls

  2025cites this paper
• Long-Term IGF-1 Maintenance in the Upper-Normal Range Has Beneficial Effect on Low-Grade Inflammation Marker in Adults with Growth Hormone Deficiency

  2025cites this paper
• A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD

  2024cites this paper
• The Double-Edged Sword of Total Antioxidant Capacity: Clinical Significance and Personal Experience

  2024cites this paper
• Growth hormone treatment in aged patients with comorbidities: A systematic review.

  2024cites this paper
• Exogenous growth hormone administration during total sleep deprivation changed the microRNA-9 and dopamine D2 receptor expressions followed by improvement in the hippocampal synaptic potential, spatial cognition, and inflammation in rats

  2023cites this paper
• Telomere length is a driving hallmark for aging-related biochemical hallmarks: evidence from the shared genetic effect and causal inference.

  2023cites this paper
• Dynamic model assuming mutually inhibitory biomarkers of frailty suggests bistability with contrasting mobility phenotypes

  2023cites this paper
• The modulatory role of growth hormone in inflammation and macrophage activation.

  2022cites this paper
• Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer

  2022cites this paper
• Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile

  2022cites this paper
• Growth hormone and insulin-like growth factor I regulation of nonalcoholic fatty liver disease.

  2022cites this paper
• Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency

  2022cites this paper
• Lipid Abnormalities in Patients With Cushing’s Disease and Its Relationship With Impaired Glucose Metabolism

  2021cites this paper
• COVID-19 and hypopituitarism

  2021cites this paper
• Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood

  2020cites this paper
• Effect of long-term growth hormone replacement on glucose metabolism in adults with growth hormone deficiency: a systematic review and meta-analysis

  2020cites this paper
• A Suggested Role of Human Growth Hormone in Control of the COVID-19 Pandemic

  2020cites this paper
• Acromegaly, inflammation and cardiovascular disease: a review

  2020cites this paper
• Safety and effectiveness of Omnitrope® in patients with growth hormone deficiency: snapshot analysis of PATRO Adults study in the Italian population

  2020cites this paper
• Growth hormone therapy in adults with growth hormone deficiency: a critical assessment of the literature

  2020cites this paper
• Pituitary stalk interruption syndrome and liver changes: From clinical features to mechanisms

  2020cites this paper
• Adult growth hormone deficiency: clinical advances and approaches to improve adherence

  2019cites this paper
• Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency

  2019cites this paper
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.

  2019cites this paper
• Appetite and food intake results from phase I studies of anamorelin

  2019cites this paper
• Identification of haptoglobin as a readout of rhGH therapy in GH deficiency.

  2019cites this paper
• NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management

  2019cites this paper
• Linking marital support to aging-related biomarkers: Both age and marital quality matter.

  2019cites this paper
• Sitagliptin decreases visceral fat and blood glucoses in women with polycystic ovarian syndrome.

  2019cites this paper
• An update on diagnosis and treatment of adult growth hormone deficiency

  2018cites this paper
• Growth hormones in chronic kidney disease

  2018influential citation
• Growth Hormone (GH) and Cardiovascular System

  2018cites this paper
• Panhypopituitarism Without GH Replacement: About Insulin Sensitivity, CRP Levels, and Metabolic Syndrome

  2018cites this paper
• Treatment of adult growth hormone deficiency with human recombinant growth hormone: an update on current evidence and critical review of advantages and pitfalls

  2018cites this paper
• Glucose Metabolism in Children With Growth Hormone Deficiency

  2018cites this paper
• Management of GH treatment in adult GH deficiency.

  2017cites this paper
• Human Growth Hormone Policy

  2017cites this paper
• The effect of growth hormone (GH) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real‐life data from the NordiNet® International Outcome Study

  2017cites this paper
• Effects of growth hormone on glucose metabolism and insulin resistance in human

  2017cites this paper
• Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment

  2017cites this paper
• The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease

  2017cites this paper
• Growth hormone delivery devices: current features and potential for enhanced treatment adherence

  2017cites this paper
• Lipid Accumulation Product: a Simple and Accurate Index for Predicting Metabolic Syndrome in Patients with Adult Growth Hormone Deficiency

  2016cites this paper
• Growth Hormone Deficiency in Prepubertal Children: Predictive Markers of Cardiovascular Disease

  2016cites this paper
• Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline.

  2016cites this paper
• Association of Serum hs‐CRP Levels With the Presence of Obesity, Diabetes Mellitus, and Other Cardiovascular Risk Factors

  2016cites this paper
• Low-dose growth hormone therapy reduces inflammation in HIV-infected patients: a randomized placebo-controlled study

  2016cites this paper
• Effect of growth hormone treatment on diastolic function in patients who have developed growth hormone deficiency after definitive treatment of acromegaly.

  2016cites this paper
• Insulin‐like growth factor I and risk of incident cancer in elderly men – results from MrOS (Osteoporotic Fractures in Men) in Sweden

  2016cites this paper
• Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects

  2016cites this paper
• Unintended positive and negative effects of drugs on lipoproteins

  2015cites this paper
• Increased diet-induced fatty streak formation in female mice with deficiency of liver-derived insulin-like growth factor-I

  2015cites this paper
• Sex differences in urine metabolites related with risk of diabetes using NMR spectroscopy: results of the study of health in pomerania

  2015cites this paper
• Reviewing the safety of GH replacement therapy in adults.

  2015cites this paper
• The association between high-sensitivity C-reactive protein concentration and diabetic nephropathy: a meta-analysis.

  2015cites this paper
• Hypopituitarism: growth hormone and corticotropin deficiency.

  2015cites this paper
• Therapeutic Class Overview Attention Deficit/Hyperactivity Disorder (ADHD) Agents and Stimulants

  2014cites this paper
• Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers

  2014cites this paper
• Cross-sectional and longitudinal relation of IGF1 and IGF-binding protein 3 with lipid metabolism.

  2014cites this paper
• Effects of Growth Hormone Releasing Hormone Treatment on Fat Redistribution, Cardiovascular Indices and Growth Hormone Secretion in HIV Lipodystrophy Principal Investigator:

  2014cites this paper
• Both low and high serum IGF-1 levels associate with increased risk of cardiovascular events in elderly men.

  2014cites this paper
• Fasting Levels of High-Sensitivity Growth Hormone Predict Cardiovascular Morbidity and Mortality

  2014cites this paper
• Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update.

  2014cites this paper
• Effects of nutrient composition of dinner on sleep architecture and energy metabolism during sleep.

  2014cites this paper
• Pituitary disease mortality: is it fiction?

  2013cites this paper
• Adult Growth Hormone Deficiency – Benefits, Side Effects, and Risks of Growth Hormone Replacement

  2013cites this paper
• Association between the ratio of insulin-like growth factor-I to insulin-like growth factor binding protein-3 and inflammation in incident automated peritoneal dialysis patients.

  2013cites this paper
• Evaluation of left ventricular mass and function, lipid profile, and insulin resistance in Egyptian children with growth hormone deficiency: A single-center prospective case-control study

  2013cites this paper
• Growth hormone replacement normalizes impaired fibrinolysis: new insights into endothelial dysfunction in patients with hypopituitarism and growth hormone deficiency.

  2013cites this paper
• Long-term effects of recombinant human GH replacement in adults with GH deficiency: a systematic review.

  2013cites this paper
• Updates in growth hormone treatment and mortality

  2013cites this paper
• Diagnosis and treatment of growth hormone deficiency in adults

  2013cites this paper
• Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity.

  2013cites this paper
• GH activity and markers of inflammation: a crossover study in healthy volunteers treated with GH and a GH receptor antagonist.

  2012cites this paper
• Growth hormone deficiency and cardiovascular risk: do we need additional markers?

  2012cites this paper
• The characterisation of growth hormone-related cardiac disease with magnetic resonance imaging & The effects of growth hormone dysregulation on adenosine monophosphate-activated protein kinase in cardiac tissue

  2012cites this paper
• Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy.

  2012cites this paper
• Genotypes associated with lipid metabolism contribute to differences in serum lipid profile of GH-deficient adults before and after GH replacement therapy.

  2012cites this paper
• Erişkinlerde büyüme hormonu tedavisi Growth hormone therapy in adults

  2012cites this paper
• Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.

  2012cites this paper
• Growth Hormone and the Cardiovascular System

  2012cites this paper
• The Potential Effects of IGF-1 and GH on Patients With Chronic Heart Failure

  2012cites this paper
• Long-Term Growth Hormone Replacement Therapy in Hypopituitary Adults

  2012cites this paper
• Isolated GHD: investigation and implication of JAK/STAT related genes before and after rhGH treatment

  2012cites this paper
• Systemic Effects of Growth Hormone in Growth Hormone Deficient Adults: A Meta-Analysis of 48 Prospective Studies

  2012influential citation
• Coexistence of growth hormone deficiency and autoimmune polyglandular syndrome type 3.

  2012cites this paper
• Epidemiología, características clínicas y morbi-mortalidad del hipopituitarismo en el Área Sanitaria de Santiago de Compostela

  2012cites this paper
• Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly

  2012cites this paper
• C-Reactive Protein and Cardiovascular Disease in Psoriasis

  2011cites this paper
• Role of Growth Hormone Deficiency and Treatment in Chronic Kidney Disease

  2011cites this paper
• Postradiation therapy hypopituitarism

  2011cites this paper
• Serum vascular endothelial growth factor (VEGF) is elevated in GH deficient adults.

  2011cites this paper
• Identification of novel GH-regulated pathway of lipid metabolism in adipose tissue: a gene expression study in hypopituitary men.

  2011cites this paper
• Effect of growth hormone (GH) on fasting and postprandial metabolism in GH deficiency.

  2010cites this paper
• The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.

  2010cites this paper
• Mortality in patients with pituitary disease.

  2010cites this paper
• Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.

  2010cites this paper
• TREATMENT OF ADULT GROWTH HORMONE DEFICIENCY: WHO, WHY AND HOW? A REVIEW.

  2010cites this paper
• The growth hormone system and cardiac function in patients with growth hormone disturbances and in the normal population.

  2010cites this paper